← FDA Drug Approvals (Drugs@FDA)
GABAPENTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2025-09-19
Drug application
- FDA Application #
ANDA218491- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GABAPENTIN
- Generic name
- GABAPENTIN
- Active ingredients
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals, Inc.
- First approval
- 2025-09-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown